NCT06360796View on ClinicalTrials.gov

Study of Pharmacokinetics and Metabolism on [(14)C]ADC189

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 24, 2023

Primary Completion Date

February 20, 2024

Study Completion Date

February 20, 2024

Conditions
PharmacokineticsMetabolism
Interventions
DRUG

[(14)C]ADC189

Each subject take a single oral dose of about 45 mg (about 100 μCi) \[(14)C\]ADC189 on Day 1 of the study, and be observed by 504 hours.

Trial Locations (1)

233004

The First Affilicated Hospital of Bengbu Medical University, Bengbu

All Listed Sponsors
lead

Jiaxing AnDiCon Biotech Co.,Ltd

INDUSTRY

NCT06360796 - Study of Pharmacokinetics and Metabolism on [(14)C]ADC189 | Biotech Hunter | Biotech Hunter